APC and chronic myelogenous leukemia, BCR-ABL1 positive: The concurrent presence of the mutated forms of APC and WAS was not specific to HB, it has been reported that dysregulation of WAS or APC relates to the onset and progression of other cancers, like decreasing WAS expression in chronic myeloid leukemia (Pereira et al., 2017) and APC mutant in colorectal cancer.